简体
  • 简体中文
  • 繁体中文
×

热门资讯> 正文

Biomea Fusion宣布公开发行证券定价

2025-10-07 20:26

  • Biomea Fusion (NASDAQ:BMEA) announced the pricing of its public offering for gross proceeds of $25 million.
  • The offer consists of 11.19M shares of its common stock and accompanying warrants to purchase an aggregate of 11.19M shares of common stock. In lieu of common stock, the company will offer to certain investors, pre-funded warrants to purchase an aggregate of up to 1M shares of its common stock and accompanying warrants to purchase an aggregate of up to 1M shares of common stock (or pre-funded warrants in lieu thereof), at an exercise price of $0.0001 per pre-funded warrant.
  • In addition, Biomea has granted the underwriters a 30-day option to purchase up to an additional 1,829,268 shares of common stock and/or warrants to purchase 1,829,268 shares of common stock at the public offering price, less underwriting discounts and commissions. The common stock and pre-funded warrants are being sold in combination with an accompanying warrant to purchase one share of common stock (or a pre-funded warrant in lieu thereof) issued for each share of common stock or pre-funded warrant sold. The accompanying warrant has an exercise price of $2.50 per share, is immediately exercisable from the date of issuance and will expire three years from the date of issuance.
  • The combined offering price of each share of common stock and accompanying common stock warrant is $2.05. The combined offering price of each pre-funded warrant and accompanying common stock warrant is $2.0499.
  • The offering is expected to close on October 8, 2025, subject to the satisfaction of customary closing conditions.
  • BMEA --25.4% premarket to $1.99.
  • Source: Press Release

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
问答大全
（工作日09：30 - 次日05：30）
客户端：
关注我们：
  • 微信公众号二维码

© 2025 深圳市时代华盛网络科技有限公司版权所有 粤ICP备16068286号